纳米技术
欧盟委员会
佣金
材料科学
业务
财务
经济政策
欧洲联盟
作者
Philippe Hartemann,Peter Hoet,Ana Proykova,Teresa F. Fernandes,Anders Baun,Wim de Jong,Juliane Filser,Arne Hensten,Carsten Kneuer,Jean‐Yves Maillard,Hannu Norppa,Martin Scheringer,S. Wijnhoven
出处
期刊:Materials Today
[Elsevier BV]
日期:2015-03-06
卷期号:18 (3): 122-123
被引量:113
标识
DOI:10.1016/j.mattod.2015.02.014
摘要
Considering emerging and newly identified health risksOn request of the European Commission, the independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) was requested to assess whether the use of nanosilver, in particular in medical care or in consumer products, could result in additional risks compared to more traditional uses of silver and whether the use of nanosilver to control bacterial growth could result in resistance of micro-organisms.The full text of the SCE-NIHR Opinion is freely accessible [1].This Comment looks at several unresolved problems that require the attention of the materials science community.Silver (Ag) materials, including those at the nanoscale (nanosilver), are widely used today for their antibacterial activity.However, the usefulness of (nano)silver in various medical applications may be limited because of the increased resistance of microorganisms against silver.The various silver compounds have different physico-chemical properties, such as solubility and surface charge, which affect their
科研通智能强力驱动
Strongly Powered by AbleSci AI